{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:23:43Z","timestamp":1788870223325,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"PRIN 2008"},{"name":"NEDD Project","award":["CUP H81J09002660007"],"award-info":[{"award-number":["CUP H81J09002660007"]}]},{"name":"Regione Lombardia, Italy"},{"name":"Ricerca Sanitaria","award":["RF-FSL352059"],"award-info":[{"award-number":["RF-FSL352059"]}]},{"name":"Progetto Ordinario 2007"},{"name":"Ricerca e Competitivit\u00e0 2007\u20132013","award":["PON_01602"],"award-info":[{"award-number":["PON_01602"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.nbd.2012.08.018","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T13:30:10Z","timestamp":1346333410000},"page":"177-189","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Targeted acetylation of NF-kappaB\/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window"],"prefix":"10.1016","volume":"49","author":[{"given":"Annamaria","family":"Lanzillotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Branca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Sarnico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Benarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Annunziato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PierFranco","family":"Spano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2012.08.018_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejphar.2011.05.015","article-title":"Ischemic insult induced apoptotic changes in PC12 cells: protection by trans resveratrol","volume":"666","author":"Agrawal","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2012.08.018_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0891-5849(02)00911-5","article-title":"Inhibition of cancer growth by resveratrol is related to its low bioavailability","volume":"33","author":"Asensi","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2012.08.018_bb0015","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1128\/MCB.21.20.7065-7077.2001","article-title":"The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression","volume":"21","author":"Ashburner","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2012.08.018_bb0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: the in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2012.08.018_bb0025","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.17.6.1304","article-title":"Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.nbd.2012.08.018_bb0030","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.lfs.2008.03.004","article-title":"The use of diversity profiling to characterize chemical modulators of the histone deacetylases","volume":"82","author":"Blackwell","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2012.08.018_bb0035","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1046\/j.1471-4159.2003.01581.x","article-title":"Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis","volume":"84","author":"Boutillier","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.08.018_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.WCB.0000111614.19196.04","article-title":"Pathophysiology of cerebral ischemia and brain trauma: similarities and differences","volume":"24","author":"Bramlett","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2012.08.018_bb0045","first-page":"1","article-title":"Attenuation by acetyl-l-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion","volume":"21","author":"Calvani","year":"1999","journal-title":"Int. J. Tissue React."},{"key":"10.1016\/j.nbd.2012.08.018_bb0050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrm1368","article-title":"Shaping the nuclear action of NF-kappaB","volume":"5","author":"Chen","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2012.08.018_bb0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/01616412.1997.11740874","article-title":"Monofilament intraluminal middle cerebral artery occlusion in the mouse","volume":"19","author":"Clark","year":"1997","journal-title":"Neurol. Res."},{"key":"10.1016\/j.nbd.2012.08.018_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/JMN:17:1:45","article-title":"AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation","volume":"17","author":"Culmsee","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2012.08.018_bb0065","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jhm.689","article-title":"Trends in thrombolytic use for ischemic stroke in the United States","volume":"5","author":"Fang","year":"2010","journal-title":"J. Hosp. Med."},{"key":"10.1016\/j.nbd.2012.08.018_bb0070","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2012.08.018_bb0075","doi-asserted-by":"crossref","first-page":"16467","DOI":"10.1074\/jbc.M412960200","article-title":"Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase","volume":"280","author":"Gan","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2012.08.018_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.nbd.2012.08.018_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/13543784.17.2.169","article-title":"Histone deacetylase inhibitors: possible implications for neurodegenerative disorders","volume":"17","author":"Hahnen","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.nbd.2012.08.018_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2005.05.009","article-title":"Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase","volume":"2","author":"Hawley","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2012.08.018_bb0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature01960","article-title":"Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan","volume":"425","author":"Howitz","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2012.08.018_bb0100","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1523\/JNEUROSCI.3670-06.2006","article-title":"Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia","volume":"26","author":"Inta","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.08.018_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/JMN:16:1:49","article-title":"Cyclic AMP response element binding protein (CREB) and CREB binding protein (CBP) in global cerebral ischemia","volume":"16","author":"Jin","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2012.08.018_bb0110","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1074\/jbc.M107942200","article-title":"Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70","volume":"277","author":"Johnson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2012.08.018_bb0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2012.08.018_bb0120","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","article-title":"Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action","volume":"321","author":"Kim","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.08.018_bb0125","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1471-4159.2009.06212.x","article-title":"The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain","volume":"110","author":"Kim","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.08.018_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1523\/JNEUROSCI.3200-07.2008","article-title":"Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1\/cip1) in cell cycle-independent neuroprotection","volume":"28","author":"Langley","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.08.018_bb0135","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1038\/cddis.2010.76","article-title":"The acetylation of RelA in Lys310 dictates the NF-\u03baB-dependent response in post-ischemic injury","volume":"1","author":"Lanzillotta","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2012.08.018_bb0140","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","article-title":"Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials","volume":"375","author":"Lees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2012.08.018_bb0145","first-page":"49","article-title":"Experimental models of head trauma","volume":"83","author":"Leker","year":"2002","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.nbd.2012.08.018_bb0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2010.09.005","article-title":"Neuroprotective effects of resveratrol on ischemic injury mediated by improving brain energy metabolism and alleviating oxidative stress in rats","volume":"60","author":"Li","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2012.08.018_bb0155","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","article-title":"Executive summary: heart disease and stroke statistics \u2014 2010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.nbd.2012.08.018_bb0160","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/nar\/28.8.1707","article-title":"Transcriptional repression by the insulator protein CTCF involves histone deacetylases","volume":"28","author":"Lutz","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2012.08.018_bb0165","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jnr.20293","article-title":"Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress","volume":"79","author":"Martin","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2012.08.018_bb0170","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/jcbfm.2010.229","article-title":"Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning","volume":"31","author":"Morris","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2012.08.018_bb0175","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.jcbfm.9600559","article-title":"In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning","volume":"28","author":"Pignataro","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2012.08.018_bb0180","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.cdd.4401598","article-title":"NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity","volume":"12","author":"Pizzi","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2012.08.018_bb0185","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/sj.jcbfm.9600262","article-title":"Resveratrol mimics ischemic preconditioning in the brain","volume":"26","author":"Raval","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2012.08.018_bb0190","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1007\/s11064-011-0561-8","article-title":"Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO \u2013 1 in rats","volume":"36","author":"Ren","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2012.08.018_bb0195","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/molecules15031196","article-title":"trans-Resveratrol as a neuroprotectant","volume":"15","author":"Robb","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.nbd.2012.08.018_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1097-2765(03)00223-5","article-title":"p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor","volume":"12","author":"Rocha","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2012.08.018_bb0205","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1093\/emboj\/cdg615","article-title":"Critical loss of CBP\/p300 histone acetylase activity by caspase-6 during neurodegeneration","volume":"22","author":"Rouaux","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2012.08.018_bb0210","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: a long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2012.08.018_bb0215","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1200\/JCO.2005.02.188","article-title":"Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma","volume":"23","author":"Ryan","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.nbd.2012.08.018_bb0220","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2008.05783.x","article-title":"NF-kappaB p50\/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia","volume":"108","author":"Sarnico","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.08.018_bb0225","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2119\/molmed.2011.00038","article-title":"Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries","volume":"17","author":"Shein","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.nbd.2012.08.018_bb0230","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1073\/pnas.0510341103","article-title":"The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases","volume":"103","author":"Simonini","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.08.018_bb0235","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/mnfr.201100143","article-title":"Resveratrol and health \u2014 a comprehensive review of human clinical trials","volume":"55","author":"Smoliga","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.nbd.2012.08.018_bb0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biopsych.2008.09.002","article-title":"Experience-dependent epigenetic modifications in the CNS","volume":"65","author":"Sweatt","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2012.08.018_bb0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.nbd.2012.08.018_bb0250","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1046\/j.1471-4159.1999.721707.x","article-title":"Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system","volume":"72","author":"Turnley","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.08.018_bb0255","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.febslet.2010.11.047","article-title":"SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model","volume":"585","author":"Wang","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2012.08.018_bb0260","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2012.08.018_bb0265","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/jcb.23431","article-title":"Cellular and molecular effects of resveratrol in health and disease","volume":"113","author":"Yu","year":"2012","journal-title":"J. Cell. Biochem."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112003051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112003051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:21:32Z","timestamp":1542759692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996112003051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":53,"alternative-id":["S0969996112003051"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2012.08.018","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}